Orchard Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch ORTX and buy or sell other stocks, options, and ETFs commission-free!

About ORTX

Orchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. 

CEO
Bobby Gaspar
CEOBobby Gaspar
Employees
259
Employees259
Headquarters
London, Greater London
HeadquartersLondon, Greater London
Founded
2018
Founded2018
Employees
259
Employees259

ORTX Key Statistics

Market cap
2.12B
Market cap2.12B
Price-Earnings ratio
-0.41
Price-Earnings ratio-0.41
Dividend yield
Dividend yield
Average volume
728.34K
Average volume728.34K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.8875
52 Week high$0.8875
52 Week low
$0.3601
52 Week low$0.3601
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.